Results for the substance ocrelizumab:

OCREVUS 920mg 40mg/ml solution for injection EGIS ORIGINAL
MEDICINE

Chemical substance: ocrelizumab

ATC code: L04AG08 • Antineoplastic and immunomodulating agents | Immunosuppressants | Monoclonal antibodies

46823.52 RON

C2

P-RF

OCREVUS 300mg 30mg/ml concentrate for solution for infusion EGIS ORIGINAL
MEDICINE

Chemical substance: ocrelizumab

ATC code: L04AG08 • Antineoplastic and immunomodulating agents | Immunosuppressants | Monoclonal antibodies

24864.53 RON

C2

P-RF

OCREVUS 300mg concentrate for solution for infusion EGIS ORIGINAL
MEDICINE

Chemical substance: ocrelizumab

ATC code: L04AG08 • Antineoplastic and immunomodulating agents | Immunosuppressants | Monoclonal antibodies

P-RF